Number of the records: 1
Dendritic cell-based immunotherapy (DCVAC/OvCa) withchemotherapy in patients with platinum-sensitive, relapsed,epithelial ovarian carcinoma: Survival analysis of a phase II,open-label, randomized, multicenter trial (study SOV02)
- 1.
SYSNO ASEP 0506303 Document Type A - Abstract R&D Document Type The record was not marked in the RIV R&D Document Type Není vybrán druh dokumentu Title Dendritic cell-based immunotherapy (DCVAC/OvCa) withchemotherapy in patients with platinum-sensitive, relapsed,epithelial ovarian carcinoma: Survival analysis of a phase II,open-label, randomized, multicenter trial (study SOV02) Author(s) Cibula, D. (CZ)
Rob, L. (CZ)
Mallmann, P. (DE)
Knapp, P. (PL)
Bartůňková, J. (CZ)
Spíšek, R. (CZ)
Hassan, H. I. (CZ)
Pecen, Ladislav (UIVT-O) RID, SAI, ORCID
Klat, J. (CZ)
Chovanec, J. (CZ)Source Title Gynecologic Oncology. - : Elsevier - ISSN 0090-8258
Roč. 154, suppl. 1 (2019), s. 18-18Action Annual Meeting of the Society of Gynecologic Oncology /50./ Event date 16.03.2019 - 19.03.2019 VEvent location Honolulu Country US - United States Event type WRD Language eng - English Country US - United States Institutional support UIVT-O - RVO:67985807 DOI 10.1016/j.ygyno.2019.04.046 Workplace Institute of Computer Science Contact Tereza Šírová, sirova@cs.cas.cz, Tel.: 266 053 800 Year of Publishing 2020
Number of the records: 1